Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sanofi secures EC approval for Sarclisa for third-line multiple myeloma

pharmaceutical-business-reviewJune 08, 2020

Tag: Sanofi , multiple myeloma , Sarclisa , pom-dex

PharmaSources Customer Service